Annual D&A
$20.47 M
+$1.53 M+8.10%
December 31, 2023
Summary
- As of February 7, 2025, ASND annual depreciation & amortization is $20.47 million, with the most recent change of +$1.53 million (+8.10%) on December 31, 2023.
- During the last 3 years, ASND annual D&A has risen by +$9.68 million (+89.74%).
- ASND annual D&A is now at all-time high.
Performance
ASND Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 30, 2024
Summary
- ASND quarterly depreciation & amortization is not available.
Performance
ASND Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 30, 2024
Summary
- ASND TTM depreciation & amortization is not available.
Performance
ASND TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ASND Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.1% | - | - |
| 3 y3 years | +89.7% | - | - |
| 5 y5 years | +1870.3% | - | - |
ASND Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.4% | ||||
| 5 y | 5-year | at high | +173.4% | ||||
| alltime | all time | at high | +3706.1% |
Ascendis Pharma A/S Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $4.86 M(-8.3%) | $20.45 M(-0.1%) |
| Dec 2023 | $20.47 M(+8.1%) | $5.30 M(+3.0%) | $20.47 M(-1.0%) |
| Sep 2023 | - | $5.15 M(+0.2%) | $20.69 M(+5.7%) |
| Jun 2023 | - | $5.14 M(+5.3%) | $19.58 M(+3.8%) |
| Mar 2023 | - | $4.88 M(-11.5%) | $18.87 M(-0.4%) |
| Dec 2022 | $18.94 M(+4.0%) | $5.52 M(+36.6%) | $18.94 M(+2.2%) |
| Sep 2022 | - | $4.04 M(-8.7%) | $18.52 M(-1.2%) |
| Jun 2022 | - | $4.43 M(-10.7%) | $18.75 M(+0.3%) |
| Mar 2022 | - | $4.95 M(-2.9%) | $18.69 M(+2.6%) |
| Dec 2021 | $18.21 M(+68.8%) | $5.10 M(+19.5%) | $18.21 M(+11.4%) |
| Sep 2021 | - | $4.27 M(-2.2%) | $16.34 M(+8.9%) |
| Jun 2021 | - | $4.36 M(-2.5%) | $15.01 M(+14.9%) |
| Mar 2021 | - | $4.48 M(+38.4%) | $13.07 M(+21.1%) |
| Dec 2020 | $10.79 M(+44.1%) | $3.23 M(+10.0%) | $10.79 M(+10.1%) |
| Sep 2020 | - | $2.94 M(+21.6%) | $9.80 M(+9.4%) |
| Jun 2020 | - | $2.42 M(+9.9%) | $8.96 M(+9.1%) |
| Mar 2020 | - | $2.20 M(-2.0%) | $8.22 M(+9.7%) |
| Dec 2019 | $7.49 M(+620.7%) | $2.24 M(+7.0%) | $7.49 M(+34.9%) |
| Sep 2019 | - | $2.10 M(+25.4%) | $5.55 M(+49.5%) |
| Jun 2019 | - | $1.67 M(+13.7%) | $3.71 M(+63.6%) |
| Mar 2019 | - | $1.47 M(+382.1%) | $2.27 M(+118.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $1.04 M(+25.0%) | $305.40 K(+17.6%) | $1.04 M(+11.3%) |
| Sep 2018 | - | $259.70 K(+12.5%) | $933.60 K(+1.3%) |
| Jun 2018 | - | $230.80 K(-5.1%) | $921.20 K(+3.0%) |
| Mar 2018 | - | $243.20 K(+21.7%) | $894.40 K(+7.6%) |
| Dec 2017 | $831.30 K(+10.9%) | $199.90 K(-19.2%) | $831.20 K(+1.6%) |
| Sep 2017 | - | $247.30 K(+21.2%) | $818.10 K(+8.4%) |
| Jun 2017 | - | $204.00 K(+13.3%) | $754.90 K(+0.6%) |
| Mar 2017 | - | $180.00 K(-3.6%) | $750.70 K(+0.2%) |
| Dec 2016 | $749.30 K(+21.0%) | $186.80 K(+1.5%) | $749.40 K(+2.4%) |
| Sep 2016 | - | $184.10 K(-7.9%) | $731.70 K(+3.0%) |
| Jun 2016 | - | $199.80 K(+11.8%) | $710.40 K(+7.8%) |
| Mar 2016 | - | $178.70 K(+5.7%) | $659.10 K(+6.4%) |
| Dec 2015 | $619.20 K(-7.6%) | $169.10 K(+3.9%) | $619.20 K(-1.9%) |
| Sep 2015 | - | $162.80 K(+9.6%) | $631.30 K(+1.6%) |
| Jun 2015 | - | $148.50 K(+7.0%) | $621.50 K(-3.8%) |
| Mar 2015 | - | $138.80 K(-23.4%) | $646.00 K(-3.6%) |
| Dec 2014 | $670.20 K(+24.6%) | $181.20 K(+18.4%) | $670.20 K(+37.1%) |
| Sep 2014 | - | $153.00 K(-11.6%) | $489.00 K(+45.5%) |
| Jun 2014 | - | $173.00 K(+6.1%) | $336.00 K(+106.1%) |
| Mar 2014 | - | $163.00 K | $163.00 K |
| Dec 2013 | $537.90 K(-1.6%) | - | - |
| Dec 2012 | $546.40 K | - | - |
FAQ
- What is Ascendis Pharma A/S annual depreciation & amortization?
- What is the all time high annual D&A for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual D&A year-on-year change?
- What is the all time high quarterly D&A for Ascendis Pharma A/S?
- What is the all time high TTM D&A for Ascendis Pharma A/S?
What is Ascendis Pharma A/S annual depreciation & amortization?
The current annual D&A of ASND is $20.47 M
What is the all time high annual D&A for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual depreciation & amortization is $20.47 M
What is Ascendis Pharma A/S annual D&A year-on-year change?
Over the past year, ASND annual depreciation & amortization has changed by +$1.53 M (+8.10%)
What is the all time high quarterly D&A for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly depreciation & amortization is $5.52 M
What is the all time high TTM D&A for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM depreciation & amortization is $20.69 M